A survey of navy physicians' attitudes toward the use of selective serotonin reuptake inhibitors in active duty military personnel

Military Medicine

Volumn 166, Issue 6, 2001, Pages 526-529

  Knowlan, M N ^a   Arguello, J C ^a   Stewart, F I ^a  

^a Naval Ambulatory Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HEALTH SURVEY; MEDICAL PRACTICE; NAVY; PHYSICIAN ATTITUDE; PRESCRIPTION; PSYCHOTHERAPY; SOLDIER;

EID: 0034970305     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/166.6.526     Document Type: Article

References (17)

1. The safety profile of paroxetine
2. Improvement in subjective work performance after treatment of chronic depression
3. A pharmacological profile of fluoxetine and other antidepressants on aspects of skilled performance and car handling ability
4. A review of the psychomotor effects of paroxetine
5. The behavioural toxicity of the selective serotonin reuptake inhibitors
6. The effects of antidepressants on psychomotor function with particular reference to reboxetine
7. Effects of fluoxetine on psychomotor performance, cognitive function and sleep in depressed patients
8. Psychiatric medications for deployment
9. Effects of antidepressants on human performance
10. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers
11. A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance
12. Treatment of depression and the functional capacity to work
13. Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS)
14. The mental health status of women in the Navy and Marine Corps: Preliminary findings from the perceptions of wellness and readiness assessment